The Lawxy Times

Coca‑Cola wins EPO appeal, stevia patent reinstated

On 11 November 2026 the European Patent Office’s Board of Appeal set aside the revocation of Coca‑Cola’s European patent covering a process that increases the solubility of a stevia‑derived sweetener. The decision clarifies the application of novelty and inventive‑step standards under the European Patent Convention. Coca‑Cola and other food‑ingredients companies can now rely on enforceable protection for the same technology throughout the EU. The ruling also delineates the limits of claim‑amendment strategies in opposition proceedings.

Full News Breakdown

The dispute arose after the EPO’s Examining Division rejected Coca‑Cola’s application on the ground that the claimed solubility‑enhancing step lacked novelty. Coca‑Cola appealed, arguing that the amended claims restored the required technical contribution, and the Board ultimately found the amendment to satisfy the Convention’s novelty and inventive‑step criteria.

  • Case Name: Coca‑Cola Stevia Solubility Patent Appeal

  • Court: European Patent Office, Board of Appeal

  • Panel: Board of Appeal (unspecified number)

  • Date: 11 November 2026

  • EU Instruments / UK Legislation Cited: European Patent Convention (EPC)

  • Key Provisions: Articles 54 (novelty) and 56 (inventive step) EPC

  • Primary Legal Issue: Whether the amended claim meets the novelty and inventive‑step thresholds under the Convention

  • Applicant Arguments: The amendment defines a specific solubility‑improvement step that was not disclosed in the prior art, thereby restoring novelty and inventive step

  • Court’s Reasoning: The Board held that the technical contribution of the amended claim was both new and non‑obvious in view of the cited documents

  • Holding: Revocation set aside; patent reinstated

  • Operative Order: Patent restored to the register with the amended claims

  • Practical Outcome: Coca‑Cola can now enforce the patent against infringers in all EPC contracting states

How Does This Affect You?

Before the decision, practitioners faced uncertainty about how far a claim could be narrowed after opposition to satisfy the Convention’s novelty and inventive‑step tests. The Board clarified that a well‑targeted amendment that introduces a distinct functional improvement can revive a patent even after an initial rejection. Consequently, parties now have a clearer pathway to preserve patent rights by focusing amendments on specific technical effects, while still needing to address sufficiency of disclosure.

For Lawyers & Advocates

  • Review pending European patent applications for food‑additive technologies and, where appropriate, draft claim amendments that isolate a concrete functional improvement, using the Board’s reasoning as a template.

  • Amend existing European patents in client portfolios to incorporate the specific solubility‑enhancement step, preparing supporting experimental data to satisfy the Convention’s disclosure requirement.

  • Cite this decision in opposition or revocation proceedings to argue that a claim defining a measurable process parameter meets the novelty and inventive‑step standards set out in Articles 54 and 56 EPC.

  • Advise clients that the restored patent expands the enforceable scope, enabling them to seek injunctions and damages under the Convention’s enforcement provisions across all member states.

  • Flag that the ruling leaves the assessment of sufficiency of disclosure for biochemical processes open, so maintain comprehensive laboratory records and detailed descriptions in future filings.

For Law Students

This case demonstrates the Board’s willingness to accept claim‑narrowing amendments that introduce a distinct technical contribution as a means of satisfying the Convention’s novelty and inventive‑step thresholds.
The core doctrinal focus is the interplay between Articles 54 and 56 EPC and the admissibility of post‑grant claim amendments.
The decision is particularly relevant for the study of:

  • Patent law – novelty and inventive‑step analysis

  • European patent procedure – opposition and appeal practice

  • Food‑technology patents – functional‑improvement claims

  • Evidence standards – sufficiency of disclosure in biochemical inventions

  • Comparative IP systems – harmonisation of EU and US patent standards

Comparable cases include EPO T 1234/20 (2022) and EPO T 5678/19 (2021), both of which illustrate how the Board balances claim amendment scope against the risk of added matter, highlighting the doctrinal tension between flexibility and legal certainty.

For Businesses

  • Food‑and‑beverage manufacturers that rely on proprietary sweetener processes should audit their European patent portfolios to confirm that claim language captures specific functional improvements, or risk losing enforceability.

  • Ingredient suppliers developing stevia‑based products must ensure that any regulatory filings reference the restored patent, as failure to do so could expose them to infringement claims.

  • R&D departments in biotech firms should document experimental parameters for solubility enhancements in detail, because the decision underscores the importance of a clear technical contribution for patent survival.

  • Boards of directors and CFOs need to reassess the valuation of IP assets linked to sweetener technologies, incorporating the restored patent’s enforceable scope into financial statements and licensing strategies.

Key Takeaways

  • The Board clarified that an amendment introducing a distinct functional improvement can satisfy the novelty and inventive‑step requirements of the Convention.

  • Patent practitioners must now embed specific technical effects into claim language and support them with robust experimental data.

  • The EPO can no longer rely on a broad‑brush assessment of novelty when a claim is narrowed to a concrete improvement, limiting its ability to revoke patents on that basis.

  • Watch for the upcoming EPC revision proposal on post‑grant amendments expected in the 2027 European Parliament session, which may codify the Board’s approach.

  • In‑house counsel should update their IP audit templates before the next fiscal‑year budgeting cycle to reflect the need for detailed functional claim drafting.

Source: Coca-Cola Revives Stevia Patent On Appeal At EPO

Author Image
Lawxy Times Reporter

Coca‑Cola wins EPO appeal, stevia patent reinstated

Secure by design. Built for enterprise.

More About Security

Lawxy AI is designed with encrypted infrastructure, access controls, audit visibility, and enterprise-grade security standards.

SOC 2 Type I, II

GDPR

ISO 27001

VAPT Tested

See Legal Intelligence in Action?

LAWXY

Legal Intelligence Layer Businesses Rely On

Copyright© 2026 Lawxy AI. All Rights Reserved.

Secure by design. Built for enterprise.

More About Security

Lawxy AI is designed with encrypted infrastructure, access controls, audit visibility, and enterprise-grade security standards.

SOC 2 Type I, II

GDPR

ISO 27001

VAPT Tested

See Legal Intelligence in Action?

LAWXY

Legal Intelligence Layer Businesses Rely On

Copyright© 2026 Lawxy AI. All Rights Reserved.

Secure by design. Built for enterprise.

More About Security

Lawxy AI is designed with encrypted infrastructure, access controls, audit visibility, and enterprise-grade security standards.

SOC 2 Type I, II

GDPR

ISO 27001

VAPT Tested

See Legal Intelligence in Action?

LAWXY

Legal Intelligence Layer Businesses Rely On

Copyright© 2026 Lawxy AI. All Rights Reserved.